ChiCTR2400088154 版本V1.0 版本创建时间2024/08/13 04:17:20 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2400088154 

最近更新日期:

Date of Last Refreshed on:

2024-08-13 04:17:01 

注册时间:

Date of Registration:

2024-08-13 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

经皮穴位电刺激对剖宫产患者围术期低体温的影响

Public title:

The effect of transcutaneous acupoint electrical stimulation on perioperative hypothermia in patients undergoing cesarean section

注册题目简写:

English Acronym:

研究课题的正式科学名称:

经皮穴位电刺激对剖宫产患者围术期低体温的影响

Scientific title:

The effect of transcutaneous acupoint electrical stimulation on perioperative hypothermia in patients undergoing cesarean section

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

黄健 

研究负责人:

黄健 

Applicant:

Huang Jian 

Study leader:

Huang Jian 

申请注册联系人电话:

Applicant telephone:

+86 139 8519 8778

研究负责人电话:

Study leader's
telephone:

+86 139 8519 8778

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

wwwjianhuang@126.com

研究负责人电子邮件:

Study leader's E-mail:

wwwjianhuang@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

贵州省贵阳市云岩区百花大道34号

研究负责人通讯地址:

贵州省贵阳市云岩区百花大道34号

Applicant address:

No.34 Baihua Avenue, Yunyan District, Guiyang City, Guizhou Provinc

Study leader's address:

No.34 Baihua Avenue, Yunyan District, Guiyang City, Guizhou Provinc

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

贵州省第三人民医院

Applicant's institution:

The Third People's Hospital of Guizhou

研究负责人所在单位:

贵州省第三人民医院

Affiliation of the Leader:

The Third People's Hospital of Guizhou

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

LL-2024-012

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

贵州省第三人民医院

Name of the ethic committee:

The Third People's Hospital of Guizhou

伦理委员会批准日期:

Date of approved by ethic committee:

2024-08-01 00:00:00

伦理委员会联系人:

周厚荣

Contact Name of the ethic committee:

Zhou Hourong

伦理委员会联系地址:

贵州省贵阳市云岩区百花大道34号

Contact Address of the ethic committee:

No.34 Baihua Avenue, Yunyan District, Guiyang City, Guizhou Provinc

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 851 8485 2809

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

贵州省第三人民医院

Primary sponsor:

The Third People's Hospital of Guizhou

研究实施负责(组长)单位地址:

贵州省贵阳市云岩区百花大道34号

Primary sponsor's address:

No.34 Baihua Avenue, Yunyan District, Guiyang City, Guizhou Provinc

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

贵州省

市(区县):

Country:

China

Province:

Guizhou Province

City:

单位(医院):

贵州省第三人民医院

具体地址:

贵州省贵阳市云岩区百花大道34号

Institution
hospital:

The Third People's Hospital of Guizhou

Address:

No.34 Baihua Avenue, Yunyan District, Guiyang City, Guizhou Provinc

经费或物资来源:

由贵州省中医药管理局(2021XMSB00028909)和贵州省卫生健康委员会(gzwkj2021-267)资助

Source(s) of funding:

Funded by the Guizhou Provincial Administration of Traditional Chinese Medicine (2021XMSB00028909) and the Guizhou Provincial Health Commission (gzwkj2021-267)

研究疾病:

腰麻后剖宫产产妇低体温  

Target disease:

hypothermia

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

I期临床试验 

Study phase:

1

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

观察经皮穴位电刺激对腰硬联合麻醉下择期剖宫产患者围术期低体温的影响  

Objectives of Study:

To observe the effect of transcutaneous electrical acupoint stimulation on perioperative hypothermia during combined spinal-epidural anesthesia for elective cesarean section.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

①拟于腰硬联合麻醉下行剖宫产术; ②美国麻醉医师协会(ASA)分级I~II级; ③年龄>18岁; ④单胎足月妊娠(孕周≥37周); ⑤自愿加入试验并签署知情同意书。

Inclusion criteria

①a willingness to undergo an elective cesarean section under combined spinal–epidural anaesthesia. ②an American Society of Anesthesiologists (ASA) physical status of I or II. ③an age of at least 18 years. ④a singleton pregnancy (with a gestational age of at least 37 weeks). ⑤voluntary participation in the trial and the signature of a clinical informed consent form for this study.

排除标准:

①入室时鼓膜温度低于 36.0℃ 或高于 37.5℃; ②有出凝血障碍,中枢神经系统疾病,脊柱疾病,穿刺点皮肤感染,循环不稳定等腰麻穿刺禁忌症者; ③术中失血 ≥400mL,手术时间 ≥90min; ④术前2周内服用影响体温调节药物,妊娠合并糖尿病、高血压或甲状腺功能减退等代谢性疾病。

Exclusion criteria:

①When entering the room, the tympanic membrane temperature was found to be below 36.0 °C or above 37.5 °C. ②Patients contraindicated to spinal anaesthesia include those with bleeding disorders, coagulation disorders, central nervous system diseases, spinal diseases, skin infection at the puncture point, or circulatory instability. ③Intraoperative blood loss of ≥400ml and a surgery time of ≥90 min. ④Drugs that affected thermoregulation were administered within two weeks before surgery. Pregnancy is complicated by metabolic diseases, such as diabetes, hypertension, or hypothyroidism.

研究实施时间:

Study execute time:

From 2024-08-01 00:00:00 To 2024-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-08-15 00:00:00 To 2024-12-10 00:00:00

干预措施:

Interventions:

组别:

试验组

样本量:

40

Group:

experimental group

Sample size:

干预措施:

经皮穴位电刺激

干预措施代码:

Intervention:

Transcutaneous acupoint electrical stimulation

Intervention code:

组别:

对照组

样本量:

40

Group:

control group

Sample size:

干预措施:

干预措施代码:

Intervention:

without transcutaneous acupoint electrical stimulation

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

贵州省 

市(区县):

 

Country:

China

Province:

Guizhou Province

City:

单位(医院):

贵州省第三人民医院 

单位级别:

三级 

Institution
hospital:

The Third People's Hospital of Guizhou

Level of the institution:

Tertiary

测量指标:

Outcomes:

指标中文名:

核心体温

指标类型:

主要指标

Outcome:

core body temperature

Type:

Primary indicator

测量时间点:

围术期

测量方法:

Measure time point of outcome:

Perioperative period

Measure method:

指标中文名:

寒战

指标类型:

次要指标

Outcome:

shivering

Type:

Secondary indicator

测量时间点:

术中

测量方法:

Measure time point of outcome:

intraoperative

Measure method:

指标中文名:

恶心、呕吐

指标类型:

次要指标

Outcome:

nausea and vomiting

Type:

Secondary indicator

测量时间点:

术中

测量方法:

Measure time point of outcome:

Perioperative period

Measure method:

指标中文名:

低血压

指标类型:

次要指标

Outcome:

hypotension

Type:

Secondary indicator

测量时间点:

术中

测量方法:

Measure time point of outcome:

Perioperative period

Measure method:

指标中文名:

新生儿Apgar评分

指标类型:

次要指标

Outcome:

neonatal Apgar score

Type:

Secondary indicator

测量时间点:

术中

测量方法:

Measure time point of outcome:

Perioperative period

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 40 years

性别:

女性

Gender:

Female

随机方法(请说明由何人用什么方法产生随机序列):

其中一名不知情的麻醉医生采用随机数字表法将患者分为两组。

Randomization Procedure (please state who generates the random number sequence and by what method):

An unknown anesthesiologist divided the patients into two groups by random number table.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

单盲。对受试者施盲,并且严格实施研究者、操作者、统计者三分离。

Blinding:

Single blinding.Subjects were blinded and strict separation of investigator,operator and statisticians.

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

索取提供

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Data will be provided on reasonable request.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据记录于病例报告表,随后录入电子数据表。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The data is recorded in the case report form and then entered into an electronic spreadsheet.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2024-08-13 04:17:01